For: | Samiullah S, Bikharam D, Nasreen. Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained viral response. World J Gastroenterol 2012; 18(40): 5793-5798 [PMID: 23155322 DOI: 10.3748/wjg.v18.i40.5793] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i40/5793.htm |
Number | Citing Articles |
1 |
|
2 |
T. Heller, Y. Rotman, C. Koh, S. Clark, V. Haynes-Williams, R. Chang, R. McBurney, P. Schmid, J. Albrecht, D. E. Kleiner, M. G. Ghany, T. J. Liang, J. H. Hoofnagle. Long-term therapy of chronic delta hepatitis with peginterferon alfa. Alimentary Pharmacology & Therapeutics 2014; 40(1): 93 doi: 10.1111/apt.12788
|
3 |
Luan Felipo Botelho-Souza, Mariana Pinheiro Alves Vasconcelos, Alcione de Oliveira dos Santos, Juan Miguel Villalobos Salcedo, Deusilene Souza Vieira. Hepatitis delta: virological and clinical aspects. Virology Journal 2017; 14(1) doi: 10.1186/s12985-017-0845-y
|
4 |
Bhavana Tetali, Brianna Kuperus, Nikhilesh Mazumder. Identifying and Screening At-Risk Patients for Hepatitis Delta Virus: A Case Report. Cureus 2023; doi: 10.7759/cureus.33660
|
5 |
Gemma Odena, Eva Stein, Ramon Bataller. Complications of Cirrhosis. 2015; : 71 doi: 10.1007/978-3-319-13614-1_8
|
6 |
Ibrahim Halil Bahcecioglu, Abdurrahman Sahin. Treatment of Delta Hepatitis: Today and in the Future - A review. Infectious Diseases 2017; 49(4): 241 doi: 10.1080/23744235.2016.1271998
|
7 |
Mahwish Aftab, Iram Amin, Muhammad Idrees, Amjad Ali, Shazia Rafique, Shagufta Naz. Molecular epidemiology of hepatitis delta and hepatitis B viruses circulating in two major provinces (East and North-West) of Pakistan. Infection, Genetics and Evolution 2018; 64: 65 doi: 10.1016/j.meegid.2018.06.013
|
8 |
Nayantara Orekondy, Eric R. Kallwitz. A Brief Update on the Management of Hepatitis Delta. Current Gastroenterology Reports 2018; 20(12) doi: 10.1007/s11894-018-0666-1
|
9 |
Giuseppina Brancaccio, Giovanni B. Gaeta. Treatment of chronic hepatitis due to hepatitis B and hepatitis delta virus coinfection. International Journal of Antimicrobial Agents 2019; 54(6): 697 doi: 10.1016/j.ijantimicag.2019.09.012
|
10 |
Selma El Messaoudi, Ségolène Brichler, Claire Fougerou-Leurent, Emmanuel Gordien, Athenaïs Gerber, Amal Kortebi, Garance Lagadic, Miroslava Subic-Levrero, Sophie Metivier, Stanislas Pol, Anne Minello, Vlad Ratziu, Vincent Leroy, Philippe Mathurin, Laurent Alric, Fatoumata Coulibaly, Jean-Michel Pawlotsky, Fabien Zoulim, Victor de Lédinghen, Jérémie Guedj. Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide. JHEP Reports 2024; 6(8): 101070 doi: 10.1016/j.jhepr.2024.101070
|
11 |
Fulya Gunsar. Treatment of delta hepatitis. Expert Review of Anti-infective Therapy 2013; 11(5): 489 doi: 10.1586/eri.13.35
|
12 |
Ibrahim Halil Bahcecioglu, Murat Ispiroglu, Ulvi Demirel, Mehmet Yalniz. Pegylated Interferon α Therapy in Chronic Delta Hepatitis: A One-Center Experience. Hepatitis Monthly 2015; 15(3) doi: 10.5812/hepatmon.24366
|